Is Adipose Tissue a Reservoir for SARS-Cov2 Spread in Covid-19 Patients?
NCT ID: NCT04427878
Last Updated: 2024-06-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
5 participants
INTERVENTIONAL
2020-08-03
2020-09-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Adipose Tissue in COVID-19
NCT04639440
Obesity, Insulin Resistance, and PASC: Persistent SARS-CoV-2
NCT05833217
Lipid Metabolism in COVID-19 Severe Pneumonia Compared With Severe Pneumonia Caused by Other Pathogen
NCT04435223
Testing the Adipose Expandability Hypothesis in Vivo During Overfeeding
NCT04583514
Safety and Immune Response of COVID-19 Vaccination in Overweight People With Excessive BMI
NCT05043272
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patients with Covid-19
biopsies of subcutaneous adipose tissue
Two 4mm punch biopsies of subcutaneous abdominal or thight adipose tissue
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
biopsies of subcutaneous adipose tissue
Two 4mm punch biopsies of subcutaneous abdominal or thight adipose tissue
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients testing positive for Covid19
* Patients affiliated to social security
* Signing of free and informed consent
Exclusion Criteria
* adults under guardianship or curatorship,
* pregnant women,
* persons deprived of their liberty,
* persons who do not master the French language)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nice
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Nice
Nice, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20-PP-15
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.